-
1 Comment
Chemesis International Inc is currently in a long term downtrend where the price is trading 24.5% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
Chemesis International Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.
Its net income has increased by 38.0% to $-10M since the same quarter in the previous year.
Finally, its free cash flow grew by 170.4% to $3M since the same quarter in the previous year.
Based on the above factors, Chemesis International Inc gets an overall score of 3/5.
| Industry | Drug Manufacturers-Specialty & Generic |
|---|---|
| Sector | Healthcare |
| ISIN | None |
| CurrencyCode | EUR |
| Exchange | F |
| PE Ratio | None |
|---|---|
| Target Price | None |
| Beta | 1.52 |
| Market Cap | 7M |
| Dividend Yield | 0.0% |
Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California, Puerto Rico, and Colombia. It offers various types of extractions, formulations, and products specializing in BHO extraction, alcohol extraction, and CO2 extraction. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CWAB.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
